The American Council on Education and 26 other national higher education organizations are backing Harvard University as it defends a lower-court victory that overturned the Trump administration’s freeze on more than $2.2 billion in federal research funding. In an amicus brief filed July 22 and highlighted by ACE on Monday, the groups asked the U.S. Court of Appeals for the First Circuit to affirm the judgment against the federal agencies involved in the funding cutoff.

The filing represents a broad institutional response to a dispute that began in spring 2025, when the administration demanded changes to Harvard’s governance, hiring, admissions and academic practices. After Harvard rejected the demands, federal officials announced a freeze affecting research grants and contracts administered by agencies including the National Institutes of Health, National Science Foundation, Department of Defense and Department of Energy. Harvard sued, characterizing the action as retaliation for refusing to surrender control over core university decisions.

U.S. District Judge Allison D. Burroughs ruled for Harvard in September 2025. The court found that the administration’s actions imposed unconstitutional conditions, amounted to retaliation for protected expression and failed to follow the procedures Congress created for terminating federal assistance over alleged civil-rights violations. The ruling vacated the freeze and termination actions and barred the government from using them to deny Harvard federal funding. The Justice Department subsequently appealed.

The associations’ new brief places institutional autonomy at the center of the appellate fight. It argues that the First Amendment protects universities’ ability to decide, on academic grounds, who teaches, what is taught, how instruction is delivered and who may study. Government attempts to reshape those decisions through financial pressure, the groups contend, threaten the “marketplace of ideas” that courts have long associated with American higher education.

The organizations do not argue that universities are exempt from federal civil-rights law. Their brief expressly condemns antisemitism and other forms of discrimination and acknowledges the government’s authority to enforce Title VI, which prohibits discrimination in federally funded programs. The central dispute, they say, is whether the executive branch may avoid the procedures Congress established for investigating violations and terminating funds.

According to the associations, the administration did not complete those processes before imposing the sweeping funding restrictions. The brief says billions of dollars in grants were initially frozen through a public announcement rather than through the statutory framework governing Title VI enforcement. That distinction is critical to the groups’ argument that the government was using research funding as political leverage rather than imposing a remedy tied to particular grants or proven violations.

The administration disputes that characterization. In its appellate arguments, the government has challenged the district court’s jurisdiction over grant termination disputes and contended that federal agencies acted within their authority as providers of public funds. It has also argued that the lower court wrongly concluded that the funding actions violated Title VI and the First Amendment. Administration officials have consistently said Harvard failed to protect Jewish students and should not assume an unconditional entitlement to taxpayer support.

ACE’s coalition says the government’s contracting and grant-making role does not eliminate constitutional limits. Even when the government pays a private organization to perform work, the brief argues, it generally may not punish that organization for unrelated protected speech or require adherence to an official political viewpoint. The associations maintain that the demands directed at Harvard went beyond oversight of individual research awards and instead targeted decisions about faculty, curriculum, admissions and institutional leadership.

The coalition includes organizations representing public and private universities, research institutions, medical schools, community colleges, governing boards and campus professionals. Among the participants are the Association of American Universities and the Association of American Medical Colleges. AAU said the funding measures threatened both institutional autonomy and the system of open inquiry that supports U.S. leadership in science and innovation. AAMC said affirming the lower court was necessary to protect academic freedom and the diversity of American higher education.

A separate brief filed by Yale University and 35 other colleges reinforced the research-focused argument. Those institutions warned that abruptly withdrawing support from one major university can disrupt collaborative projects across the wider scientific system. Modern research frequently involves investigators, specialized facilities and data networks distributed among several campuses, meaning that a funding action against one institution can delay work conducted elsewhere.

The universities also stressed that federal support frequently finances basic research with no immediate commercial return. Private companies may have little incentive to fund such early-stage work, even though it can later produce major advances. The institutions cited the long federal-university partnership behind developments in computing, medicine, defense technology and public health, arguing that unpredictable, institution-wide funding cancellations could weaken that model.

At Harvard, the freeze affected research involving cancer, Alzheimer’s disease, climate science and other fields, according to the university. Harvard established a $250 million internal fund in 2025 to stabilize affected programs while the litigation proceeded. University officials also warned at the time that the broader federal pressure campaign could eventually cost the institution as much as $1 billion annually, illustrating why even a university with a large endowment can face difficulty replacing restricted federal grants.

The associations argue that less wealthy institutions would have far fewer options. Harvard can finance extended litigation and temporarily support selected laboratories, but regional universities, medical centers and smaller private colleges may lack comparable reserves. The brief warns that allowing agencies to impose institution-wide freezes without the established enforcement process could push other schools to accept government demands rather than risk immediate research shutdowns, layoffs or canceled graduate positions.

The case therefore reaches beyond the status of Harvard’s awards. Colleges are seeking a clear legal boundary separating legitimate grant oversight and civil-rights enforcement from retaliation tied to an institution’s speech or academic choices. The administration, meanwhile, is asking the appeals court to preserve federal agencies’ ability to decide where public research money should be spent and to correct what it views as errors in the district court’s jurisdictional and constitutional analysis.

Briefing before the First Circuit remains underway, and the appeals court has not yet issued a merits decision. Whatever the outcome, the case is likely to shape how universities respond to future federal investigations and funding threats. An affirmance would strengthen procedural and First Amendment protections invoked by colleges; a reversal could give the executive branch wider latitude to suspend research support while pursuing disputes over campus governance and compliance.